Atrial Fibrillation Clinical Trials in Brasov
2 recruitingBrasov, Romania
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Not Applicable
Conduction System Pacing Versus Biventricular Pacing After Atrioventricular Node Ablation
Heart FailureAtrial FibrillationTachycardia-induced Cardiomyopathy
University Medical Centre Ljubljana82 enrolled10 locationsNCT05467163